Total planned funding: $502,740,210
Clear active filters
FHI 360
NGO
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Mozambique | $109,079,145 |
Nigeria | $47,938,708 |
South Africa | $46,936,091 |
Zimbabwe | $38,458,613 |
Kenya | $35,805,963 |
Asia Regional Program | $28,526,299 |
Tanzania | $23,781,044 |
Burundi | $21,841,299 |
West Africa Region | $18,148,918 |
Zambia | $17,953,439 |
Botswana | $17,527,066 |
Ethiopia | $14,334,711 |
Vietnam | $11,517,177 |
Malawi | $10,936,922 |
Côte d'Ivoire | $10,247,280 |
Democratic Republic of the Congo | $9,940,596 |
Dominican Republic | $6,098,850 |
Indonesia | $5,026,155 |
Eswatini | $4,315,679 |
Haiti | $4,260,713 |
India | $3,723,000 |
Papua New Guinea | $3,189,171 |
Uganda | $3,060,518 |
Caribbean Region | $2,717,206 |
Lesotho | $2,292,588 |
Central America Region | $1,646,143 |
Angola | $1,085,000 |
South Sudan | $1,051,916 |
Cameroon | $700,000 |
Central Asia Region | $300,000 |
enumerations.Philippines | $300,000 |
Rwanda | $0 |
Ghana | $0 |
Organizational Types
NGO | $502,740,210 |
Program Areas
Care | $147,911,682 |
Treatment | $145,321,534 |
Prevention | $133,879,837 |
Testing | $47,566,330 |
Governance and Systems | $27,898,533 |
Management and Operations | $162,294 |
Budget Codes
HTXS: Treatment: Adult Treatment | $135,331,901 |
HKID: Care: Orphans and Vulnerable Children | $84,104,817 |
HVOP: Sexual Prevention: Other Sexual Prevention | $78,912,511 |
HVCT: Testing: HIV Testing and Counseling | $47,566,330 |
HBHC: Care: Adult Care and Support | $45,964,712 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $28,122,731 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $14,300,116 |
OHSS: Health Systems Strengthening | $14,209,081 |
PDTX: Treatment: Pediatric Treatment | $9,989,633 |
PDCS: Care: Pediatric Care and Support | $9,590,292 |
HVSI: Strategic Information | $9,025,322 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $8,805,076 |
HVTB: Care: TB/HIV | $8,251,861 |
HLAB: Laboratory Infrastructure | $4,664,130 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $3,171,987 |
HMIN: Biomedical Prevention: Injection Safety | $407,265 |
HVMS: Management and Operations | $162,294 |
HMBL: Biomedical Prevention: Blood Safety | $160,151 |
HTXD: Treatment: ARV Drugs | $0 |
Top Partner Programs
FHI 360:
$502,740,210
View countries